32 results
S-3
EX-4.5
SKYE
Skye Bioscience Inc
Shelf registration
10 May 24
4:19pm
10-K
2023 FY
EX-4.14
SKYE
Skye Bioscience Inc
Annual report
21 Mar 24
8:41pm
8-K
EX-4.1
SKYE
Skye Bioscience Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:13pm
8-K
EX-4.1
SKYE
Skye Bioscience Inc
29 Jan 24
Skye Bioscience Announces $50.25 Million Private Placement Equity Financing
8:02am
8-K
EX-4.3
SKYE
Skye Bioscience Inc
21 Aug 23
Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
8:36am
8-K
EX-4.1
8f4hogxd2p5ul
21 Aug 23
Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
8:36am
8-K
EX-4.2
thvsf
21 Aug 23
Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
8:36am
8-K
EX-4.1
y40pgn6y
28 Sep 21
Skye Bioscience Announces $7.0 Million Registered Direct Offering
8:45am
8-K
EX-4.2
ms6ebwlevv i9
28 Sep 21
Skye Bioscience Announces $7.0 Million Registered Direct Offering
8:45am
8-K
EX-4.3
p6np t7breypp8l8
28 Sep 21
Skye Bioscience Announces $7.0 Million Registered Direct Offering
8:45am
8-K
EX-4.2
qv0hw9
5 Aug 20
Emerald Bioscience Raises approximately $7.0 Million in Upsized Registered Offering
12:00am
8-K
EX-4.1
b1tfnf1
5 Aug 20
Emerald Bioscience Raises approximately $7.0 Million in Upsized Registered Offering
12:00am
8-K
EX-4.1
fugh30wym
21 Nov 19
Emerald Bioscience Announces $2.0 Million Registered Direct Offering
5:21pm